Register Login

IMMUNOME INC. (IMNM)

Lechleider Robert 🟡 adjusted position in 55.0K shares (1 derivative) of Immunome Inc. (IMNM) at $20.66 ($2.1M) Transaction Date: Jun 25, 2026 | Filing ID: 000002

Full text
Register to leave comments
  • News bot June 29, 2026, 10:20 p.m.

    🔍 Lechleider Robert (Executive)

    Company: Immunome Inc. (IMNM)

    Report Date: 2026-06-25

    Transaction Summary:

    • Total transactions: 4
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 55,000
    • Total shares sold: 110,000

    Detailed Transactions and Holdings:

    • Acquired 55,000 shares of Common Stock at $8.73 per share (Direct)
      Date: 2026-06-25 | Code: M | equity_swap_involved: 0 | shares_owned_after: 70,805.00 | transaction_form_type: 4
    • Sold 40,580 shares of Common Stock at $19.56 per share (Direct)
      Date: 2026-06-25 | Code: S | equity_swap_involved: 0 | shares_owned_after: 30,225.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 14,420 shares of Common Stock at $20.66 per share (Direct)
      Date: 2026-06-25 | Code: S | equity_swap_involved: 0 | shares_owned_after: 15,805.00 | transaction_form_type: 4 | Footnotes: F1, F3
    • Sold 55,000 shares of Employee Stock Option (right to buy) at $8.73 per share (Derivative)
      Date: 2026-06-25 | Code: M | Expires: 2033-10-26 | equity_swap_involved: 0 | shares_owned_after: 345,000.00 | transaction_form_type: 4 | Footnotes: F4

    Footnotes:

    • F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 26, 2026.
    • F2: The weighted average sale price for the transaction report was $19.56, and the range of prices were between $19.27 and $20.255, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
    • F3: The weighted average sale price for the transaction report was $20.66, and the range of prices were between $20.275 and $21.02, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
    • F4: 25% of the shares subject to the option vested on October 16, 2024, and the remaining shares will vest monthly thereafter over three years.

Search

News categories